Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INsIDER: Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

NCT05177523 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05177523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05177523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INsIDER: Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Recruiting
Start date
September 4, 2018
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms), primary progressive multiple sclerosis (ppms), relapsing-remitting multiple sclerosis (rrms), secondary-progressive multiple sclerosis (spms)